Sign in
CompletedNo phase

A Novel Cooling Vest to Protect Persons With SCI From Hyperthermia

Key facts

Who runs it
VA Office of Research and Development
Where
The Bronx, United StatesSee the site
Trial code
Status
Completed
People taking part
15 people enrolled
Started
18 Dec 2023
Ended
31 Jan 2025
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Cooling Vest
Record updated
30 April 2025

Who can take part

Age
18 years to 68 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Spinal cord injury (SCI) >1 year in duration
  • Level of SCI C4-T2, ASIA Impairment Scale A \& B
  • Gender and age-matched (±5 years) able-bodied (AB) controls
  • Euhydration (participants will be instructed to avoid caffeine and alcohol, maintain normal salt and water intake and avoid strenuous exercise for 24 hours prior to study)

Who cannot take part

  • Known cardiovascular, kidney or untreated thyroid disease
  • Diabetes mellitus
  • Acute illness or infection
  • Cardiac pacemaker or other implanted electromedical device
  • Known or suspected obstructive disease of the GI tract
  • Traumatic brain injury (mod-severe)
  • Broken, inflamed, or otherwise fragile skin
  • Pregnancy
  • BMI >30 kg/m2
  • Smoking Participants with SCI only (secondary to telemetry capsule (CorTemp®) measurement of Tcore)
  • Undergoing magnetic resonance imaging while the telemetry capsule is within the body (2-5 days)

Where in United States

  • James J. Peters VA Medical Center, Bronx, NYThe Bronx, United States

About the trial

What the trial wants to find out

Persons with higher levels of spinal cord injury (above the 6th thoracic vertebrae: Hi-SCI) are unable to maintain their core body temperature (Tcore) within the normal range (97.5-99.7 °F) when exposed to warm environments. Even limited exposure to warm temperatures can cause hyperthermia (Tcore 100.4°F) in Hi-SCI. Mild hyperthermia causes discomfort and impaired thinking, but if unchecked, can lead to permanent damage to the brain, multiple body organ failure, and death. Warm seasonal temperatures have an adverse effect on personal comfort and the ability to participate in daily social activities in persons with Hi-SCI. Interventions addressing this vulnerability to hyperthermia are limited.

Read full original descriptionShow less

A self-regulating "smart" cooling vest designed for persons with Hi-SCI, that can effectively dissipate body heat, is a novel and promising strategy to address this problem. Once the current prototype is further developed and bench-tested, the investigators will test the vest in able-bodied participants for safety and comfort. The investigators will then test the vest in participants with Hi-SCI for efficacy. The aim for the cooling vest to minimize the expected increase of 1.1°F in Tcore by at least 50 percent and increase thermal comfort, during a controlled exposure to heat (95°F). If successful, the vest will provide a promising intervention to decrease the adverse impact of warm temperatures on comfort, quality of life, and participation in societal functions for Veterans with Hi-SCI during the warmer seasons.

The 3 groups in the trial

  • Arm 1: Cooling VestTreatment being tested

    Phase 1: After satisfying bench testing criteria, AB participants will wear the wet cooling vest at maximal settings for 2 hours in the seated position in a warm thermal chamber (35°C), to determine: (1) minimum skin temperatures beneath the cooling vest and (2) subjective thermal sensation of their skin beneath the cooling vest.

    Treatment: Cooling Vest

  • Arm 2: Cooling VestTreatment being tested

    Phase 2: Participants with Hi-SCI will wear the wet vest (experimental condition) in a warm thermal chamber (35°C) for up to 2 hours in the seated position, to determine: (1) change in Tcore and (2) perception of heat and thermal comfort.

    Treatment: Cooling Vest

  • Arm 3: No VestNo study treatment, for comparison

    Phase 2: Participants with Hi-SCI will wear no vest (control condition) in a warm thermal chamber (35°C) for up to 2 hours in the seated position, to determine: (1) change in Tcore and (2) perception of heat and thermal comfort.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Development of a Novel Cooling Vest to Prevent Heat-Induced Thermoregulatory Dysfunction in Persons With Spinal Cord Injury
Record updated
30 April 2025